Citius Pharmaceuticals, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 0.5231 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 14.36M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company’s late-stage pipeline includes Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections; Halo-Lido, a corticosteroid-lidocaine topical formulation to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of ARDS. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Details
| Name | Citius Pharmaceuticals, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 23 |
| Founded | 2007 |
| Ceo | Leonard Mazur |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| Isin | US17322U3068 |
| Cusip | 17322U306 |
| Cik | 0001506251 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Leonard L. Mazur | Co-Founder, Chief Executive Officer, Chairman and Secretary |
| Myron Z. Holubiak | Co-Founder and Executive Vice Chairman |
| Dr. Myron S. Czuczman M.D. | Executive Vice President and Chief Medical Officer |
| Jaime Bartushak | Chief Business Officer and Chief Financial Officer |
| Gary F. Talarico | Executive Vice President of Operations |
| Ilanit Allen | Vice President of Investor Relations and Corporate Communications |
| Dr. Alan Lader Ph.D. | Senior Vice President and Head of Clinical Operations and Quality Assurance |
| Dhananjay G. Wadekar | Senior Vice President of Business Strategy |
| Kelly Creighton Ph.D. | Executive Vice President of Chemistry, Manufacturing and Controls |
| Nikolas Burlew | Executive Vice President of Quality Assurance |
Contact
| Address | 11 Commerce Drive, First Floor, Cranford, New Jersey 07016, United States |
| Phone | 908 967 6677 |
| Website | https://citiuspharma.com |